The Avenues Study: Dual Use Cessation

Description

The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.

Conditions

Smoking Cessation, Electronic Cigarette Use

Talk to us

Study Overview

On this page

Study Details

Study overview

The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.

Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape

The Avenues Study: Dual Use Cessation

Condition
Smoking Cessation
Intervention / Treatment

-

Contacts and Locations

Madison

University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, United States, 53792

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Able to read and communicate in English
  • * Willing to set a quit date to quit smoking cigarettes in the next 30 days
  • * Willing and medically able to use varenicline and nicotine patches
  • * Smoking ≥ 5 cigarettes per day for the past 6 months
  • * Vaping weekly for at least 6 months
  • * Willing to stop using nicotine replacement or varenicline
  • * Willing to stop using bupropion (i.e., Wellbutrin, Zyban) if they are currently using it only for smoking cessation
  • * Plans to move out of the area for the next 12 months
  • * Currently in treatment for psychosis or bipolar disorder
  • * If they are currently taking bupropion for non-smoking cessation reasons (e.g., Wellbutrin for depression)
  • * Currently pregnant or breastfeeding. If a participant becomes pregnant while in the study, they will be allowed to continue in the study but will no longer receive study medications. They will also be asked to return any unused study medications.

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Megan E Piper, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2028-07